Transgene Market Cap

Transgene has a market cap or net worth of €135.02 million as of August 15, 2025. Its market cap has increased by 0.49% in one year.

Market Cap

135.02M

Enterprise Value

128.75M

Revenue

6.35M

Ranking

n/a

PE Ratio

n/a

Stock Price

€1.02

Market Cap Chart

Since March 30, 1998, Transgene's market cap has decreased from 151.86M to 135.02M, a decrease of -11.09%. That is a compound annual growth rate of -0.43%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	135.02M	50.44%
Dec 31, 2024	89.75M	-34.86%
Dec 29, 2023	137.78M	-16.38%
Dec 30, 2022	164.76M	-33.52%
Dec 31, 2021	247.84M	79.73%
Dec 31, 2020	137.90M	6.95%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
EssilorLuxottica Société anonyme	123.36B
Sanofi	103.59B
Sartorius Stedim Biotech	17.26B
bioMérieux	14.85B
Eurofins Scientific SE	12.02B
Ipsen	9.28B
ABIVAX Société Anonyme	4.53B
Virbac	2.77B

Market Cap Rankings